Ann R. Klee - 24 May 2024 Form 4 Insider Report for Sotera Health Co (SHC)

Role
Director
Signature
Matthew J. Klaben, Attorney-in-Fact
Issuer symbol
SHC
Transactions as of
24 May 2024
Net transactions value
$0
Form type
4
Filing time
29 May 2024, 16:37:01 UTC
Previous filing
20 May 2024
Next filing
19 May 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SHC Common Stock, $0.01 par value per share ("Common Stock") Award $0 +20,089 +23% $0.000000 106,824 24 May 2024 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These securities consist of 20,089 Restricted Stock Units ("RSUs") that were granted on May 24, 2024, pursuant to the terms of an RSU agreement under the Sotera Health Company 2020 Omnibus Incentive Plan. Each RSU represents the Reporting Person's right to receive one share of Common Stock, subject to vesting conditions. The RSUs will vest in full on the earlier of (i) the first anniversary of the date of grant, or (ii) the date immediately prior to the Issuer's next regular annual shareholders meeting, subject to the Reporting Person's continued service as a non-employee director of the Issuer through such date.
F2 Consist of 20,089 RSUs and 86,735 shares of Common Stock, including 79,752 shares of vested Common Stock and 6,983 shares of unvested Common Stock. The unvested shares of Common Stock will vest on a daily basis pro rata through May 27, 2025.

Remarks:

The Power of Attorney for Ms. Klee is filed as an exhibit to the Form 3 filed with the Securities and Exchange Commission on November 20, 2020, which is hereby incorporated by reference.